Pharmaceutico – Evaluation of Pathyadi Varti Anjana Containing Moringa Oleifera Seeds: An Analytical Perspective

Authors

  • Prem Kumar Goud PhD Scholar, Department of Shalakya Tantra, All India Institute of Ayurveda, New Delhi, India. Author
  • Akanksha Thakur PhD Scholar, Department of Shalakya Tantra, All India Institute of Ayurveda, New Delhi, India. Author
  • Shreya Dhanaji Bhosale PhD Scholar, Department of Rasa Shastra and Bhaishajya Kalpna, All India Institute of Ayurveda, New Delhi, India. Author
  • Manjusha Rajagopala Professor and HOD, Department of Shalakya, Tantra, All India Institute of Ayurveda, New Delhi, India. Author

Keywords:

Anjana, Cataract, High-performance thin layer chromatography, Pathyadi Varti, Phytochemical

Abstract

Background: Blur vision, particularly due to cataracts, remains a significant global public health concern, especially  in rural and underserved populations. Ayurvedic formulations such as Pathyadi Varti (PV), which comprises four  potent herbo-mineral ingredients with psycho-physical Kaphahara properties, have shown promise in addressing  age-related ocular degeneration. This study evaluates the physicochemical properties, organoleptic characteristics,  and phytochemical composition of PV. Material and Methods: PV was prepared following classical Ayurvedic guidelines. Analytical evaluations included  organoleptic and physicochemical assessments, qualitative phytochemical screening, and high-performance thin layer chromatography for the detection. Results: Results highlighted PV’s quality, stability, and therapeutic potential. Phytochemical screening revealed the  presence of alkaloids, tannins, flavonoids, proteins/amino acids, and saponins. Conclusion: These findings underscore the potential of PV as a complementary therapeutic agent in cataract  management. Its antioxidant properties, combined with the presence of key phytochemicals, suggest a role in  mitigating oxidative stress, a key contributor to cataract formation. Integrating such formulations into modern  therapeutic strategies may address unmet needs in managing age-related visual impairment. Vision is the most crucial human sense, utilizing over 30% of the  brain’s processing capacity. Consequently, the fear of losing eyesight  ranks among the top health-related anxieties.[1] Globally, cataracts  are the leading cause of treatable blindness. In India, they account  for blindness in approximately 0.73% of the population.[2] Research  suggests that around 14.25% of older adults in India are affected by  cataracts, with higher rates found among women and the elderly. 

 

Downloads

Download data is not yet available.

References

1. Scott AW, Bressler NM, Ffolkes S, Wittenborn JS, Jorkasky J. Public attitudes about eye and vision health. JAMA Ophthalmol. 2016;134(10):1111-8. doi: 10.1001/jamaophthalmol.2016.2627

2. Wolde Kentayiso T, Alto AA, Abebaw Z, Misker D, Boynito WG. Cataract prevalence and its associated factors among adult people aged 40 years and above in south Ari district, southern Ethiopia. Adv Public Health. 2023;2023:1996608. doi: 10.1155/2023/1996608

3. Singh S, Pardhan S, Kulothungan V, Swaminathan G, Ravichandran JS, Ganesan S, Sharma T, Raman R. The prevalence and risk factors for cataract in rural and urban India. Indian J Ophthalmol. 2019;67(4):477-83. doi: 10.4103/ijo.IJO-1127-17

4. Sharma S. In: Kashinath Shastri P, editor. Rasa tarangini. 8th ed., Sloka no. 73-5. New Delhi: Motilal Banarasidas Publication; 2014. p. 534. 5. Sharma S. In: Kashinath Shastri P, editor. Rasa tarangini. 8th ed., Sloka no. 106-7. New Delhi: Motilal Banarasidas Publication; 2014. p. 540.

6. Anonymous. The ayurvedic pharmacopoeia of India (Formulations). 1st ed., Vol. 2-3., Part 2. New Delhi: Government of India, Ministry of Health and Family Welfare, The Controller of Publications; 2010. p. 104, 116, 159-180, 263.

7. Anonymous. The ayurvedic pharmacopoeia of India, Appendix-3, (3.3). 1st ed., Vol. 1., Part 2. New Delhi: Government of India,

Ministry of Health and Family Welfare; 2007. p. 191.

8. Anonymous. The Ayurvedic Pharmacopoeia of India, Appendix-2 (2.2.10). 1st ed., Vol. 1., Part 2. New Delhi: Government of India, Ministry of Health and Family Welfare; 2007. p. 141.

9. Anonymous. The ayurvedic pharmacopoeia of India, Appendix-2 (2.2.3). 1st ed., Vol. 1., Part 2. New Delhi: Government of India, Ministry of Health and Family Welfare; 2007. p. 140.

10. Anonymous. The ayurvedic pharmacopoeia of India, Appendix-2 (2.2.4). 1st ed., Vol. 1., Part 2. New Delhi: Government of India, Ministry of Health and Family Welfare; 2007. p. 140.

11. Anonymous. The ayurvedic pharmacopoeia of India, Appendix-2, (2.2.7). 1st ed., Vol. 1., Part 2. New Delhi: Government of India, Ministry of Health and Family Welfare; 2007. p. 141.

12. Anonymous. The ayurvedic pharmacopoeia of India, Appendix-2, (2.2.8). 1st ed., Vol. 1., Part 2. New Delhi: Government of India, Ministry of Health and Family Welfare; 2007. p. 141.

13. Anonymous, The ayurvedic pharmacopoeia of India, Appendix-2, (2.2.6- 2.2.7). 1st ed., Vol. 1., Part 2. New Delhi: Government of India, Ministry of Health and Family Welfare; 2007. p. 143.

14. Khandelwal KR. Practical pharmacognosy techniques and experiments. 16th ed. Pune: Nirali Prakashan; 2006. p. 149-56.

Downloads

Published

2025-08-11

How to Cite

Goud, P. K., Thakur, A., Bhosale, S. D., & Rajagopala, M. (2025). Pharmaceutico – Evaluation of Pathyadi Varti Anjana Containing Moringa Oleifera Seeds: An Analytical Perspective . International Research Journal of Ayurveda and Yoga, 8(5), 23-28. https://journals.acspublisher.com/index.php/irjay/article/view/22531